{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T13:10:35Z","timestamp":1688303435814},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T00:00:00Z","timestamp":1371686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00391-013-0497-5","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T11:01:58Z","timestamp":1371553318000},"page":"479-488","source":"Crossref","is-referenced-by-count":0,"title":["Digitalis und Theophyllin","Digitalis and theophylline"],"prefix":"10.1007","volume":"46","author":[{"given":"M.","family":"Gosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dovjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,20]]},"reference":[{"key":"497_CR1","doi-asserted-by":"crossref","unstructured":"Ritz E, Schoner W (2008) From Digitalis purpurea to toad skin. An historical view of digitalis-like mammalian hormones. Dtsch Med Wochenschr 133(51\u201352):2690\u20132694. DOI 10.1055\/s-0028-1105877","DOI":"10.1055\/s-0028-1105877"},{"key":"497_CR2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/FTD.0b013e31825c88bb","volume":"34","author":"Jelliffe","year":"2012","unstructured":"Jelliffe RW (2012) Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy. Ther Drug Monit 34(4):368\u2013377","journal-title":"Ther Drug Monit"},{"key":"497_CR3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/clc.4960120714","volume":"12","author":"Silverman","year":"1989","unstructured":"Silverman ME (1989) William Withering and an account of the foxglove. Clin Cardiol 12(7):415\u2013418","journal-title":"Clin Cardiol"},{"key":"497_CR4","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1055\/s-0028-1106490","volume":"100","author":"Grosse-Brockhoff","year":"1975","unstructured":"Grosse-Brockhoff F, Hausamen TU (1975) 200 years heart therapy digitalis. William Withering and the 1st century of digitalis therapy. Dtsch Med Wochenschr 100(39):1980\u20131991","journal-title":"Dtsch Med Wochenschr"},{"key":"497_CR5","first-page":"358","volume":"14","author":"Meyer","year":"1974","unstructured":"Meyer KF (1974) Claude-Adolphe Nativelle. Pharmacist discovers digitaline. J Am Pharm Assoc 14(7):358\u2013360","journal-title":"J Am Pharm Assoc"},{"key":"497_CR6","first-page":"490","volume":"43","author":"Minkowski","year":"1902","unstructured":"Minkowski O (1902) \u00dcber Theocin (Theophyllin) als Diureticum. Ther Gegenwart 43:490\u2013493","journal-title":"Ther Gegenwart"},{"key":"497_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2222.1982.tb01641.x","volume":"12","author":"Schultze-Werninghaus","year":"1982","unstructured":"Schultze-Werninghaus G, Meier-Sydow J (1982) The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S.R. Hirsch in Frankfurt (Main) 1922. Clin Allergy 12:211\u2013215","journal-title":"Clin Allergy"},{"key":"497_CR8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/01.CIR.99.9.1265","volume":"99","author":"Hauptmann","year":"1999","unstructured":"Hauptmann PJ, Kelly RA (1999) Digitalis. Circulation 99:1265\u20131270","journal-title":"Circulation"},{"key":"497_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.CIR.80.1.65","volume":"80","author":"Ferguson","year":"1989","unstructured":"Ferguson DW, Berg WJ, Sanders JS et al (1989) Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation 80(1):65\u201377","journal-title":"Circulation"},{"key":"497_CR10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.95.08040637","volume":"8","author":"Rabe","year":"1995","unstructured":"Rabe KF, Magnussen H, Dent G (1995) Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 8(4):637\u2013642","journal-title":"Eur Respir J"},{"key":"497_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1681.1978.tb00707.x","volume":"5","author":"Polson","year":"1978","unstructured":"Polson JB, Krzanowski JJ, Goldman AL, Szentivanyi A (1978) Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol 5(5):535\u2013539","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"497_CR12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1164\/ajrccm\/145.5.1087","volume":"145","author":"Bj\u00f6rck","year":"1992","unstructured":"Bj\u00f6rck T, Gustafsson LE, Dahl\u00e9n SE (1992) Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 145(5):1087\u20131091","journal-title":"Am Rev Respir Dis"},{"key":"497_CR13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1164\/rccm.2110060","volume":"166","author":"Ito","year":"2002","unstructured":"Ito K, Caramori G, Lim S et al (2002) Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med 166(3):392\u2013396","journal-title":"Am J Respir Crit Care Med"},{"key":"497_CR14","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"Camm","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of a trial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369\u20132429","journal-title":"Eur Heart J"},{"key":"497_CR15","doi-asserted-by":"crossref","unstructured":"Veldhuisen DJ van, Van Gelder IC, Ahmed A, Gheorghiade M (2013) Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not? Eur Heart J (E-pub ahead of print)","DOI":"10.1093\/eurheartj\/ehs483"},{"key":"497_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00391-011-0268-0","volume":"45","author":"Gosch","year":"2012","unstructured":"Gosch M, Roller RE, B\u00f6hmdorfer B et al (2012) Management and therapy of atrial fibrillation in geriatric patients. Z Gerontol Geriatr 45(1):55\u201366","journal-title":"Z Gerontol Geriatr"},{"key":"497_CR17","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP et al (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347(23):1825\u20131833","journal-title":"N Engl J Med"},{"key":"497_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199307013290101","volume":"329","author":"Packer","year":"1993","unstructured":"Packer M, Gheorghiade M, Young JB et al (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 329(1):1\u20137","journal-title":"N Engl J Med"},{"key":"497_CR19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"The","year":"1997","unstructured":"The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336(8):525\u2013533","journal-title":"N Engl J Med"},{"key":"497_CR20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","volume":"289","author":"Rathore","year":"2003","unstructured":"Rathore SS, Curtis JP, Wang Y et al (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289(7):871\u2013878","journal-title":"JAMA"},{"key":"497_CR21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa021266","volume":"347","author":"Rathore","year":"2002","unstructured":"Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347(18):1403\u20131411","journal-title":"N Engl J Med"},{"key":"497_CR22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijcard.2010.04.021","volume":"150","author":"Ather","year":"2011","unstructured":"Ather S, Peterson LE, Divakaran VG et al (2011) Digoxin treatment in heart failure \u2013 unveiling risk by cluster analysis of DIG data. Int J Cardiol 150(3):264\u2013269. DOI 10.1016\/j.ijcard.2010.04.021","journal-title":"Int J Cardiol"},{"key":"497_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00391-012-0345-z","volume":"46","author":"Dovjak","year":"2013","unstructured":"Dovjak P (2013) Diastolic heart failure: heart failure with preserved ejection fraction. Z Gerontol Geriatr 46(1):71\u201381","journal-title":"Z Gerontol Geriatr"},{"key":"497_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","volume":"114","author":"Ahmed","year":"2006","unstructured":"Ahmed A, Rich MW, Fleg JL et al (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114(5):397\u2013403","journal-title":"Circulation"},{"key":"497_CR25","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787\u20131847","journal-title":"Eur Heart J"},{"key":"497_CR26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurjhf\/hft010","volume":"15","author":"Gheorghiade","year":"2013","unstructured":"Gheorghiade M, Patel K, Filippatos G et al (2013) Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur J Heart Fail 15(5):551\u2013559","journal-title":"Eur J Heart Fail"},{"key":"497_CR27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0735-1097(89)90561-5","volume":"13","author":"Gheorghiade","year":"1989","unstructured":"Gheorghiade M, Hall V, Lakier JB, Goldstein S (1989) Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol 13(1):134\u2013142","journal-title":"J Am Coll Cardiol"},{"key":"497_CR28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/oxfordjournals.eurheartj.a015311","volume":"18","author":"The","year":"1997","unstructured":"The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group (1997) Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. Eur Heart J 18(4):649\u2013654","journal-title":"Eur Heart J"},{"key":"497_CR29","unstructured":"B\u00c4K, KBV, AWMF (2012) Nationale VersorgungsLeitlinie COPD. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/nvl-003l_S3_COPD_abgelaufen.pdf"},{"key":"497_CR30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0032-1302626","volume":"66","author":"Kardos","year":"2012","unstructured":"Kardos P, Vogelmeier C, Worth H (2012) The new GOLD document. Pneumologie 66(8):493\u2013496. DOI 10.1055\/s-0032-1310053","journal-title":"Pneumologie"},{"key":"497_CR31","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1183\/09031936.95.08111915","volume":"8","author":"Gayan-Ramirez","year":"1995","unstructured":"Gayan-Ramirez G, Janssens S, Himpens B, Decramer M (1995) Mechanism of theophylline-induced inotropic effects on foreshortened canine diaphragm. Eur Respir J 8(11):1915\u20131921","journal-title":"Eur Respir J"},{"key":"497_CR32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00101-009-1536-x","volume":"58","author":"Friege","year":"2009","unstructured":"Friege B, Friege L, Pelz J et al (2009) Bronchial asthma and chronic obstructive pulmonary disease with acute exacerbation: preclinical differential diagnostic and emergency treatment. Anaesthesist 58(6):611\u2013622","journal-title":"Anaesthesist"},{"key":"497_CR33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1532-5415.2012.03922.x","volume":"60","author":"Fick","year":"2012","unstructured":"Fick DM, Semla TP (2012) 2012 American Geriatrics Society Beers Criteria: new year, new criteria, new perspective. J Am Geriatr Soc 60(4):614\u2013615. DOI 10.1111\/j.1532-5415.2012.03922.x","journal-title":"J Am Geriatr Soc"},{"key":"497_CR34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/CPP46072","volume":"46","author":"Gallagher","year":"2008","unstructured":"Gallagher P, Ryan C, Byrne S et al (2008) STOPP (Screening Tool of Older Person\u2019s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72\u201383","journal-title":"Int J Clin Pharmacol Ther"},{"key":"497_CR35","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107(31\u201332):543\u2013551"},{"key":"497_CR36","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1055\/s-0028-1091275","volume":"133","author":"Wehling","year":"2008","unstructured":"Wehling M (2008) Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA). Dtsch Med Wochenschr 133(44):2289\u20132291","journal-title":"Dtsch Med Wochenschr"},{"key":"497_CR37","doi-asserted-by":"crossref","unstructured":"Mann E, B\u00f6hmdorfer B, Fr\u00fchwald T et al (2012) Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr 124(5\u20136):160\u2013169","DOI":"10.1007\/s00508-011-0061-5"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-013-0497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-013-0497-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-013-0497-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T12:31:07Z","timestamp":1688301067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-013-0497-5"}},"subtitle":["Alt und entbehrlich?","Old and superfluous?"],"short-title":[],"issued":{"date-parts":[[2013,6,20]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1007\/s00391-013-0497-5","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,20]]}}}